Polfa Lublin courting investors to expand and diversify infusion exports

It is possible that the deadline for filing inquiries for purchasing a 10% stake in Polfa Lublin will be mid-December. If so, the Treasury Ministry will start exclusive negotiations with a single buyer at the beginning of 2001. Beforehand, investors will be allowed to do a due diligence of Polfa' s standing. The companies most often mentioned are Fresenius, Baxterpol and Polfa Boleslawiec. All these companies are tied to foreign capital and have strong positions on the Polish market. The first two are active in the field of infusion medicines, and Polfa Boleslawiec in the medical equipment sector. " Our company needs a specialist investor, which would allow us to develop the entire field of our present activity," said Polfa Lublin president Tadeusz Duszynski. He declined to reveal the investment needs of Polfa Lublin. He has only indicated that the company would like an investor in order to expand in the field of infusion medicines, increasing its assortment and its exports. Polfa Lublin's target countries would be those of the former Soviet Union. (Prawo i Gospodarka, page 1, 3)